vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Claritev Corp (CTEV). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $246.6M, roughly 1.5× Claritev Corp). AdvanSix Inc. runs the higher net margin — -0.8% vs -32.7%, a 31.9% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs 6.2%). Claritev Corp produced more free cash flow last quarter ($36.4M vs $36.1M). Over the past eight quarters, AdvanSix Inc.'s revenue compounded faster (3.4% CAGR vs 2.5%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
ASIX vs CTEV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $246.6M |
| Net Profit | $-2.8M | $-80.6M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | -3.1% |
| Net Margin | -0.8% | -32.7% |
| Revenue YoY | 9.4% | 6.2% |
| Net Profit YoY | -892.9% | 41.6% |
| EPS (diluted) | $-0.11 | $-4.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $246.6M | ||
| Q3 25 | $374.5M | $246.0M | ||
| Q2 25 | $410.0M | $241.6M | ||
| Q1 25 | $377.8M | $231.3M | ||
| Q4 24 | $329.1M | $232.1M | ||
| Q3 24 | $398.2M | $230.5M | ||
| Q2 24 | $453.5M | $233.5M | ||
| Q1 24 | $336.8M | $234.5M |
| Q4 25 | $-2.8M | $-80.6M | ||
| Q3 25 | $-2.6M | $-69.8M | ||
| Q2 25 | $31.4M | $-62.6M | ||
| Q1 25 | $23.3M | $-71.3M | ||
| Q4 24 | $352.0K | $-138.0M | ||
| Q3 24 | $22.3M | $-391.4M | ||
| Q2 24 | $38.9M | $-576.7M | ||
| Q1 24 | $-17.4M | $-539.7M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | -3.1% | ||
| Q3 25 | -0.9% | 4.1% | ||
| Q2 25 | 7.7% | 6.9% | ||
| Q1 25 | 7.7% | 4.2% | ||
| Q4 24 | -3.9% | -17.8% | ||
| Q3 24 | 7.5% | -146.7% | ||
| Q2 24 | 11.5% | -224.4% | ||
| Q1 24 | -7.0% | -207.4% |
| Q4 25 | -0.8% | -32.7% | ||
| Q3 25 | -0.7% | -28.4% | ||
| Q2 25 | 7.7% | -25.9% | ||
| Q1 25 | 6.2% | -30.8% | ||
| Q4 24 | 0.1% | -59.4% | ||
| Q3 24 | 5.6% | -169.8% | ||
| Q2 24 | 8.6% | -247.0% | ||
| Q1 24 | -5.2% | -230.1% |
| Q4 25 | $-0.11 | $-4.88 | ||
| Q3 25 | $-0.10 | $-4.23 | ||
| Q2 25 | $1.15 | $-3.81 | ||
| Q1 25 | $0.86 | $-4.38 | ||
| Q4 24 | $0.02 | $-8.49 | ||
| Q3 24 | $0.82 | $-24.25 | ||
| Q2 24 | $1.43 | $-35.78 | ||
| Q1 24 | $-0.65 | $-33.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $16.8M |
| Total DebtLower is stronger | — | $4.6B |
| Stockholders' EquityBook value | $815.2M | $-173.9M |
| Total Assets | $1.7B | $4.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $16.8M | ||
| Q3 25 | $23.7M | $39.2M | ||
| Q2 25 | $18.4M | $56.4M | ||
| Q1 25 | $8.3M | $23.1M | ||
| Q4 24 | $19.6M | $16.8M | ||
| Q3 24 | $17.3M | $86.6M | ||
| Q2 24 | $12.1M | $48.8M | ||
| Q1 24 | $20.6M | $58.7M |
| Q4 25 | — | $4.6B | ||
| Q3 25 | — | $4.5B | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $4.5B | ||
| Q4 24 | — | $4.5B | ||
| Q3 24 | — | $4.5B | ||
| Q2 24 | — | $4.5B | ||
| Q1 24 | — | $4.5B |
| Q4 25 | $815.2M | $-173.9M | ||
| Q3 25 | $818.2M | $-101.8M | ||
| Q2 25 | $823.7M | $-39.9M | ||
| Q1 25 | $794.4M | $14.8M | ||
| Q4 24 | $774.6M | $84.0M | ||
| Q3 24 | $766.4M | $207.6M | ||
| Q2 24 | $746.6M | $603.4M | ||
| Q1 24 | $713.2M | $1.2B |
| Q4 25 | $1.7B | $4.9B | ||
| Q3 25 | $1.7B | $5.0B | ||
| Q2 25 | $1.6B | $5.1B | ||
| Q1 25 | $1.6B | $5.1B | ||
| Q4 24 | $1.6B | $5.2B | ||
| Q3 24 | $1.5B | $5.3B | ||
| Q2 24 | $1.5B | $5.7B | ||
| Q1 24 | $1.5B | $6.4B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 304.87× | ||
| Q4 24 | — | 53.67× | ||
| Q3 24 | — | 21.73× | ||
| Q2 24 | — | 7.48× | ||
| Q1 24 | — | 3.85× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $66.3M |
| Free Cash FlowOCF − Capex | $36.1M | $36.4M |
| FCF MarginFCF / Revenue | 10.0% | 14.8% |
| Capex IntensityCapex / Revenue | 7.7% | 12.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $-12.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $66.3M | ||
| Q3 25 | $26.6M | $19.9M | ||
| Q2 25 | $21.1M | $61.2M | ||
| Q1 25 | $11.4M | $-30.1M | ||
| Q4 24 | $64.2M | $-33.4M | ||
| Q3 24 | $57.3M | $72.8M | ||
| Q2 24 | $50.2M | $18.5M | ||
| Q1 24 | $-36.2M | $49.7M |
| Q4 25 | $36.1M | $36.4M | ||
| Q3 25 | $66.0K | $-16.3M | ||
| Q2 25 | $-7.2M | $36.6M | ||
| Q1 25 | $-22.6M | $-68.9M | ||
| Q4 24 | $29.8M | $-63.8M | ||
| Q3 24 | $26.8M | $41.1M | ||
| Q2 24 | $16.7M | $-7.0M | ||
| Q1 24 | $-71.6M | $19.2M |
| Q4 25 | 10.0% | 14.8% | ||
| Q3 25 | 0.0% | -6.6% | ||
| Q2 25 | -1.7% | 15.2% | ||
| Q1 25 | -6.0% | -29.8% | ||
| Q4 24 | 9.1% | -27.5% | ||
| Q3 24 | 6.7% | 17.8% | ||
| Q2 24 | 3.7% | -3.0% | ||
| Q1 24 | -21.3% | 8.2% |
| Q4 25 | 7.7% | 12.1% | ||
| Q3 25 | 7.1% | 14.7% | ||
| Q2 25 | 6.9% | 10.2% | ||
| Q1 25 | 9.0% | 16.8% | ||
| Q4 24 | 10.4% | 13.1% | ||
| Q3 24 | 7.7% | 13.8% | ||
| Q2 24 | 7.4% | 10.9% | ||
| Q1 24 | 10.5% | 13.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
CTEV
Segment breakdown not available.
